Journal of the American College of Cardiology, 2010-02, Vol.55 (7), p.688-696
2010
Details
- Autor(en) / Beteiligte
- Titel
- The Year in Heart Failure
- Ist Teil von
- Journal of the American College of Cardiology, 2010-02, Vol.55 (7), p.688-696
- Ort / Verlag
- United States: Elsevier Inc
- Erscheinungsjahr
- 2010
- Link zum Volltext
- Quelle
- Access via ScienceDirect (Elsevier)
- Beschreibungen/Notizen
- Differential expressions of several miRNAs have been observed between normal and cardiomyopathy tissues (11), and changes in miRNA expression have also been observed after ventricular unloading with mechanical assist devices (12,13). Because each miRNA can be linked to an array of downstream processes, the potential for manipulating such signals to reverse pathologic phenotypes is promising, as has been demonstrated in proof-of-concept studies (14). There is much debate over methodologies of how to define preventable readmissions and appropriateness of adjustments. [...]we still lack a mechanism to explore why readmissions occur in individual patients, which may be a prerequisite for improvement.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0735-1097eISSN: 1558-3597DOI: 10.1016/j.jacc.2009.10.028Titel-ID: cdi_proquest_miscellaneous_733585808
- Format
- –
- Schlagworte
- Biomarkers - metabolism, Cardiology, cardiomyopathy, Cardiotonic Agents, Cardiovascular, Cardiovascular disease, Central Venous Pressure - physiology, Clinical trials, Clinical Trials as Topic, Defibrillators, Implantable, Disease Management, Electric Countershock, Exercise, Gender differences, Gene expression, Genetic Testing, Heart failure, Heart Failure - epidemiology, Heart Failure - genetics, Heart Failure - physiopathology, Heart Failure - therapy, Heart-Assist Devices, Humans, Internal Medicine, Medical prognosis, Mens health, MicroRNAs - metabolism, Mortality, Myocarditis - therapy, Myocytes, Cardiac - cytology, Natriuretic Peptides - metabolism, Peptides, Practice Guidelines as Topic, Renal Insufficiency - physiopathology, Renal Insufficiency - therapy, Rodents, Stem Cell Transplantation, Stem cells, Stroke Volume, Studies, Vasodilator Agents, ventricular assist devices